Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Manitoba

$27,000.00

Investigating molecular trajectories of sepsis pathophysiology using proteomics

EF 2025-26

Résumé
Annually, over 40,000 Canadians are afflicted by sepsis, a dangerous over-response of the immune system to infection, causing organ failure and death. Sepsis claims numerous lives, burdens global healthcare, and traumatizes patients and their families. Sepsis treatments focus on giving antibiotics, managing organ failure, and controlling symptoms - not at tackling the root causes of the condition. Past research has tried to develop more effective, targeted sepsis treatments, investigating how a small number of proteins in the blood change within sepsis patients. Unfortunately, this approach has often missed the bigger picture of complex biology, and has not investigated how protein concentrations may change over time as sepsis progresses. Using an advanced technique called proteomics, we will investigate a wider array of proteins (thousands) than past research. Also, by considering how protein concentrations change in a given patient with time, this project aims to identify new markers for early sepsis diagnosis and prognosis, and new targets for biological treatments that can be customized to individual patient needs. We will recruit sepsis patients from the adult intensive care unit (ICU) at Health Sciences Centre (HSC) Winnipeg, and will regularly take blood samples over a period of two weeks. Proteins will be isolated from the blood and quantified with a precise tool called mass spectrometry. Clinical information, such as ICU treatments and outcomes, patient demographic information, and types of infection will be correlated with proteomics results in an attempt to uncover novel biological mechanisms and therapeutic targets associated with sepsis severity and death, assisting the design of much-needed personalized and precision treatments for this deadly disease.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
572692
Name
Husmann James H
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating molecular trajectories of sepsis pathophysiology using proteomics
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Biobank; Bioinformatics; Biomarkers; Critical Illness; Intensive Care Unit; Mass Spectrometry; Molecular Biology; Precision Medicine; Proteomics; Sepsis
Abstract
Annually, over 40,000 Canadians are afflicted by sepsis, a dangerous over-response of the immune system to infection, causing organ failure and death. Sepsis claims numerous lives, burdens global healthcare, and traumatizes patients and their families. Sepsis treatments focus on giving antibiotics, managing organ failure, and controlling symptoms - not at tackling the root causes of the condition. Past research has tried to develop more effective, targeted sepsis treatments, investigating how a small number of proteins in the blood change within sepsis patients. Unfortunately, this approach has often missed the bigger picture of complex biology, and has not investigated how protein concentrations may change over time as sepsis progresses. Using an advanced technique called proteomics, we will investigate a wider array of proteins (thousands) than past research. Also, by considering how protein concentrations change in a given patient with time, this project aims to identify new markers for early sepsis diagnosis and prognosis, and new targets for biological treatments that can be customized to individual patient needs. We will recruit sepsis patients from the adult intensive care unit (ICU) at Health Sciences Centre (HSC) Winnipeg, and will regularly take blood samples over a period of two weeks. Proteins will be isolated from the blood and quantified with a precise tool called mass spectrometry. Clinical information, such as ICU treatments and outcomes, patient demographic information, and types of infection will be correlated with proteomics results in an attempt to uncover novel biological mechanisms and therapeutic targets associated with sepsis severity and death, assisting the design of much-needed personalized and precision treatments for this deadly disease.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Husmann, James H
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~